Baker Ellis Asset Management LLC Amgen Inc Transaction History

Baker Ellis Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $189,199 - $209,903	-810 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $44,382 - $51,720	-200 Reduced 19.8%	810 $202,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $218,543 - $260,246	1,010 New	1,010 $232,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $167,540 - $186,318	-714 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $141,236 - $173,316	714 New	714 $168,000
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $97,391 - $108,816	-577 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $96,526 - $110,207	577	577 $108,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Baker Ellis Asset Management LLC with notifications on news.